文献速递湿疹皮炎与荨麻疹

特应性皮炎与多种疾病的关联:基于人群队列的严重程度依赖性模式

Multimorbidity and atopic dermatitis in a population-based cohort: severity-dependent association with distinct nonatopic multimorbidity patterns.
PubMed 文献 · Br J Dermatol · 2026-01-01

结果显示AD患者非特应性多种疾病风险增高(aOR 1.47),中重度AD更高(aOR 1.74),且存在口面部及心脏代谢等独特模式。

要点

  • AD患者非特应性多种疾病风险增加,中重度者风险更高。
  • AD严重程度与多种疾病数量呈剂量依赖性关联。
  • AD患者存在口面部及代谢综合征样独特共病模式。

核心结论

  • AD患者,尤其是中重度患者,更易发生非特应性多种疾病,并呈现口面部及心脏代谢疾病的独特模式。

主要发现

  • 3242名(8.7%)参与者患有AD。
  • AD患者非特应性多种疾病的比值比为1.47,中重度AD的调整比值比为1.74,轻度为1.41。
  • 非特应性多种疾病程度越高关联越强,≥5种疾病时达2.09倍。
  • 识别出五种不同的多种疾病类别,其中口面部类别仅见于AD患者,另一类似代谢综合征的类别在AD中有更多呼吸系统参与及心脏代谢差异。

关键数值与推荐

  • 多种疾病定义为终生存在至少两种疾病,非特应性多种疾病排除哮喘、鼻炎和食物过敏。
  • 复合患病评分(cMS)用于指示多种疾病程度。
  • AD严重程度基于患者导向湿疹测量(POEM)评估。

临床怎么用

  • 应提高对AD患者跨学科管理的意识,关注口面部及心脏代谢共病。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Atopic dermatitis (AD) has characteristics of a systemic disease due to underlying systemic inflammation, which is supported by reports of various comorbidities. OBJECTIVES: To examine the associations between AD and (nonatopic) multimorbidity in a population-based cohort from the northern Netherlands and to identify differences in multimorbidity patterns between participants with multimorbidity and no AD. METHODS: We assessed the lifetime prevalence of 52 diseases, from 15 domains, combining data from questionnaires, medication records and clinical assessments within the Lifelines Cohort. Lifetime AD was self-reported, physician-diagnosed and disease severity based on the Patient-Oriented Eczema Measure. Multimorbidity was defined as the lifetime presence of at least two diseases, while nonatopic multimorbidity excluded asthma, rhinitis and food allergy. A composite morbidity score (cMS) indicated the degree of multimorbidity. We analysed associations of AD and AD severity with multimorbidity and cMS using binary and multinomial logistic regression, adjusting for age and sex, and additionally adjusting for socioeconomic and lifestyle factors. Patterns of nonatopic multimorbidity based on disease domains were explored using latent class analysis, stratified by AD presence. RESULTS: Of 37 193 participants, 3242 (8.7%) had AD. The odds for nonatopic multimorbidity were 1.47-fold higher in participants with AD, particularly for those with moderate-to-severe disease (adjusted odds ratio 1.74 vs. 1.41 for mild disease). The association strengthened with higher degrees of nonatopic multimorbidity, reaching 2.09-fold for ≥ 5 diseases. When considering atopic diseases in the definition of multimorbidity and the cMS, the associations with AD were even stronger. Further adjustments for socioeconomic and lifestyle factors were corroborative. We identified five distinct multimorbidity classes among individuals with and without AD, with two differing across the groups. One class, characterized by the orofacial domain, was only present among those with AD, while another class - resembling the metabolic syndrome - had more of a respiratory contribution to AD with further differences regarding cardiometabolic involvement. CONCLUSIONS: Participants with AD, especially moderate-to-severe disease, are more likely to experience (nonatopic) multimorbidity and showed unique patterns of nonatopic multimorbidity with regard to orofacial and cardiometabolic diseases. Our findings highlight the importance of promoting awareness for interdisciplinary approaches to managing patients with AD. An author video to accompany this article is available online. Atopic dermatitis is a condition that causes red, itchy and inflamed skin. It is also known as eczema. It affects approximately 1 in 10 adults worldwide. Eczema can affect more than just the skin. In some cases, it can affect other organs and body systems because of inflammation throughout the whole body. In this study, we wanted to find out if people with eczema are more likely to have other long-term diseases. We also looked for specific patterns in the types of other health conditions they experience. We studied health data from more than 37,000 adults from a large group of people in the northern Netherlands. People in the study reported if they had ever been diagnosed with eczema by a doctor. We then checked if they had other diseases, like asthma, diabetes, heart disease and many more. Using a questionnaire, we asked how severe their eczema was. We found that about 9 in 100 people in the large study group had eczema. More people with the condition had at least two other diseases than people without eczema. This was even likelier for people with more severe eczema. The more diseases a person had, the stronger the link was with eczema. Finally, we found different patterns in the types of health conditions when people had eczema. We saw differences in diseases related to the mouth, as well as diseases affecting the heart and how the body handles sugar and fat. These findings suggest that people with eczema require combined care. This will involve different health specialists working together.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Miltner LA, Loman L, Almansa Ortiz J, et al. Multimorbidity and atopic dermatitis in a population-based cohort: severity-dependent association with distinct nonatopic multimorbidity patterns. Br J Dermatol. 2026. PMID: 41308082. doi:10.1093/bjd/ljaf475

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。